Case CIDP Elva Gabriella

Embed Size (px)

Citation preview

  • 8/19/2019 Case CIDP Elva Gabriella

    1/17

    RSUD ARIFIN ACHMAD

    Fakultas Kedokteran UNRI

    SMF/ BAGIAN SARAFSekretariat : SMF Saraf – Irna Medikal Lantai 4

    Jl. Diponegoro No. 2 Telp. (0761) 7026225

    P K A N ! A R U

    S"A"US PASIN

    Na#a Koass :l!" G"#riell" Dep"ri

    N I M $ N U K :0$0%11&6'0

    Pe#%i#%in& :r. Rii S*i"nr"+ Sp.S

    I' IDN"I"AS PASIN

     N"," N-. M

    ,*r && "*n

    Jeni el",in ere,p*"n

    Al"," "ir "ng"r"-"n

    Ag"," Il",

    S"* per"3in"n 4"3in

    eer""n IRT

    T"ngg"l M"* RS 7 J*li 201'

    T"ngg"l e,eri""n 10 J*li 201'

    Mei"l Reor %5 %7 7$

    II' ANAMNSIS ("*o"n",ne")

    Kelu(an Uta#a

    e," p"" "nggo" ger" #"3"

    1

  • 8/19/2019 Case CIDP Elva Gabriella

    2/17

    Ri)a*at Pen*akit Sekaran&

    8 2 "*n SMRS p"ien ,engel*"n le," p"" "nggo" ger" #"3".

    e," er"i e"r" i#"8i#" "" p"ien #"r* "" #"ng*n p"gi+ p"ien i" 

    "p" ,engger""n "in-". G"ngg*"n BAB "n BA4 i"ng"l p"ien.

    8 1 ,ingg* SMRS p"ien ,engel*"n e,", inggi eng"n #oro -"ng

    ,el*" i"re" p*ngg*ng "n #oong. "ien e,p" ir"3" i RS "ir 

    "ng"r"-"n el"," & "ri+ l"l* e,*i"n i r** e RSD AA.

    Ri)a*at Pen*akit Da(ulu

    8 "ien #el*, pern" ,eneri" el*"n eperi ini e#el*,n-".

    8 Ri3"-" r"*," (8)

    8 Ri3"-" DM (8)

    8 Ri3"-" ipereni (8)

    8 Ri3"-" #"* l"," (8)

    Ri)a*at Pen*akit Keluar&a

    Ti" "" el*"rg" -"ng ,eneri" pen-"i -"ng er*p".

    RSUM ANAMNSIS

    8 "ien N-. M && "*n+ ,"* RSD AA eng"n el*"n ele,""n p""

    "nggo" ger" #"3" e" 2 "*n SMRS. 1 ,ingg* SMRS+ p"ien e,",

    ier"i #oro -"ng ,el*" i"re" p*ngg*ng "n #oong.

    III' PMRIKSAAN

    A' KADAAN UMUM

    Te"n"n "r" 9 "n"n 9 110/70 ,,:g+ iri 9 110/70 ,,:g

    Den-* n"i 9 "n"n 9 7 ; /,n+ er"*r

    iri 9 %0 ; /,n+ er"*r

    J"n*ng 9 :R 9 %0 ; /,n+ ir"," 9 er"*r  

    "r* 9 Repir"i 9 2' ;/,n ipe 9 "#o,inoor""l

    S"* Gi

  • 8/19/2019 Case CIDP Elva Gabriella

    3/17

    2. N'II -+0ti.us/

    4"n"n 4iri 4eer"ng"n

    D"-" pengli""n

    "p"ng p"n"ng

    engen"l"n 3"rn"

     N

     N

     N

     N

     N

     N

    Ti" "" el"in"n

    &. N'III -+.ulo#otorius/

    4"n"n 4iri 4eer"ng"n

    oi

    *pil  Ben* 

      *r"n

    Ger" #ol" ,""

    Re?le p*pil

      "ng*ng

      Ti" l"ng*ng

    (8)

    B*l"

    & ,,

     N

    (@)

    (@)

    (8)

    B*l"

    & ,,

     N

    (@)

    (@)

    Ti" "" el"in"n

    '. N' I1 -"rok(learis/

    4"n"n 4iri 4eer"ng"n

    Ger" #ol" ,"" N N Ti" "" el"in"n

    5. N' 1 -"ri&e#inus/

    4"n"n 4iri 4eer"ng"n

    Moori 

    Seni#ili"

    Re?le orne"

     N

     N

    (@)

     N

     N

    (@)

    Ti" "" el"in"n

    6. N' 1I -A%dus.ens/

    4"n"n 4iri 4eer"ng"nGer" #ol" ,""

    Sr"#i,*

    De!i"i

     N

    (8)

    (8)

     N

    (8)

    (8)

    Ti" "" el"in"n

    7. N' 1II -Fa.ialis/

    4"n"n 4iri 4eer"ng"n

    Ti

    Moori 

    D"-" per""

    T"n" !oe 

    (8)

     N

     N

    (8)

    (8)

     N

     N

    (8)

    Ti" "" el"in"n

    &

  • 8/19/2019 Case CIDP Elva Gabriella

    4/17

    %. N' 1III -Akustikus/

    4"n"n 4iri 4eer"ng"n

    eneng"r"n N N Ti" "" el"in"n

    $. N' I2 -,lossofarin&eus/

    4"n"n 4iri 4eer"ng"n

    Ar* ?"ring

    D"-" per""

    Re?le ,*n"

     N

     N

     N

     N

     N

     N

    Ti" "" el"in"n

    10. N' 2 -1a&us/

    4"n"n 4iri 4eer"ng"nAr* ?"ring

    D-?oni"

     N

    (8)

     N

    (8)

    Ti" "" el"in"n

    11. N' 2I -Assesorius/

    4"n"n 4iri 4eer"ng"n

    Moori 

    Tro?i

     N

     N

    Ti" "" el"in"n

    12. N' 2II -Hi0o&lossus/

    4"n"n 4iri 4eer"ng"nMoori 

    Tro?i

    Tre,or 

    Di"rri

     N

    (8)

    (8)

     N

    (8)

    (8)

    Ti" "" el"in"n

    I1' SIS"M M+"+RIK 

    4"n"n 4iri 4eer"ng"n

    re,i" ""

      4e*""n

    Di"l

    roi,"l

      Ton*

      Tro?i

      Ger.in!ol*ner 

    5

    5

     N

    (8)

    5

    5

     N

    (8)

     Nor,"l

    re,i" #"3"

      4e*""n

    Di"l

    roi,"l

      Ton*

    0

    0

     N

    0

    0

     N

    "rei ere,i" #"3"

    '

  • 8/19/2019 Case CIDP Elva Gabriella

    5/17

      Tro?i

      Ger.in!ol*ner 

    (8)

    (8)

    B""n

      Tro?i

      Ger. in!ol*ner 

      Re?.ining per*

      Re?le re,"er 

    (8)

    Sn

    (8)

    Sn

    Ti" "" el"in"n

    1' SIS"M SNS+RIK 

    4"n"n 4iri 4eer"ng"n

    R"#"

     N-eri

    S**

    ropioepi? 

    Men*r*n

    Men*r*n

    Men*r*n

    Men*r*n

    Men*r*n

    Men*r*n

    Men*r*n

    Men*r*n

    :ipoeei

    1I' RFLKS

    4"n"n 4iri 4eer"ng"n

    Fiiologi

      Biep

      Triep

      4R 

      AR 

    (8)

    (8)

    (8)

    (8)

    (8)

    (8)

    (8)

    (8)

    Re?le ?iiologi (8)

    "ologi

      B"#ini

      "o 

      :o??,"n Tro,er 

    Re?le pri,ii? 9

      "l,o,en"l

      Sno*

    (8)

    (8)

    (8)

    (8)

    (8)

    (8)

    (8)

    (8)

    (8)

    (8)

    Re?le p"ologi (8)

    1II' FUN,SI K+RDINASI

    4"n"n 4iri 4eer"ng"n

    Te el*n* i*ngTe *,i l**

    G"i

    T"ne,

    Ro,#erg

     N N e,eri""n *,i l**g"i+ "ne, "n ro,#erg

    i" "p" il"*"n.

    1III' SIS"M +"+N+M

    Mii 9 (@) nor,"l+ i" "" inonineni" "n reenio *rin

    De?"e"i 9 (@) nor,"l i" "" inonineni" "l!i "n reenio "l!i

    Ti" "" el"in"n #erering"

    I2' PMRIKSAAN KHUSUS$LAIN

    5

  • 8/19/2019 Case CIDP Elva Gabriella

    6/17

    ". "e*e 9 i" er#""

     #. 4ernig 9 i" er#""

    . "ri 9 (8) / (8)

    . 4onr"p"ri 9 (8) / (8)

    e. >"l"!" e 9 (8)

    ?. Br*"l"!" e (8)+

    Br*

  • 8/19/2019 Case CIDP Elva Gabriella

    7/17

    Pe#eriksaan dara( rutin - 3uli 5674/

    H% : 89 &$dl

    : 9 2%+2

    e*oi 9 7.%00 /El

    "ro#%osit : 74;'666 $58>i"l Sign 9

    • TD 9 120/70 ,,:g

    • N"i 9 %0 ;/,eni

    • RR 9 2% ;/,eni

    S*. GBS 8 leroli "r"

    8 Meilpreniolon

    125 ,g / % ",

    8 "l 2 ; 1

    8 ipro?lo;"in

    500 ,g 2 ; 1

    7

    Follo) U0

  • 8/19/2019 Case CIDP Elva Gabriella

    8/17

    • T 9 &6+50

    84e*""n oo

    ' '

    1 1

    8Senori 

      @ @

      @ @

     

    J*,"

    2'/6/11

    e," e

    e,p"

    "nggo" ger" 

    "n e"

    n"?"

    84e""r"n9 o,po,eni

    8GS 9 ' M6 >58 >i"l Sign 9

    • TD 9 120/%0 ,,:g

    • N"i 9 %0 ;/,eni

    • RR 9 2% ;/,eni

    • T 9 &6+70

    84e*""n oo

    ' '

    1 1

    8Senori 

      @ @

      @ @ 

    S*. GBS 8 er"pi il"n*"n

    S"#*

    25/06/11

    e," e

    e,p"

    "nggo" ger" 

    84e""r"n9 o,po,eni

    8GS 9 ' M6 >58 >i"l Sign 9

    • TD 9 120/%0 ,,:g

    • N"i 9 70 ;/,eni

    • RR 9 20 ;/,eni

    • T 9 &6+50

    84e*""n oo' '

      1 1

    8Senori 

      @ @

      @ @

     

    S*. GBS 8 er"pi il"n*"n

    Senin

    27/6/11

    e," e

    e,p" "nggo"

    ger" 

    84e""r"n9

    o,po,eni

    8GS 9 ' M6 >58 >i"l Sign 9

    • TD 9 120/%0

    S*. GBS 8 er"pi

    il"n*"n

    %

  • 8/19/2019 Case CIDP Elva Gabriella

    9/17

    ,,:g

    •  N"i 9 70

    ;/,eni

    •  RR 9 20

    ;/,eni

    • T 9 &6+50

    84e*""n oo

    '

    '

      2

    2

    84R 9 @/@

    8Biep 9 @/@

    8Senori   @ @

      @ @

     

    Sel""

    2%/6/11

    e," e

    e,p"

    "nggo" ger" 

    84e""r"n9 o,po,eni

    8GS 9 ' M6 >58 >i"l Sign 9

    • TD 9 120/%0 ,,:g

    • N"i 9 %0 ;/,eni

    • RR 9 2' ;/,eni

    • T 9 &6+50

    84e*""n oo

    ' '

      2 2

    8Senori 

      @ @

      @ @

     

    S*. GBS 8 er"pi il"n*"n

    $

  • 8/19/2019 Case CIDP Elva Gabriella

    10/17

    PM!AHASAN

    PNDAHULUAN

    Sinro," G*ill"in8B"rre (SGB) ""* -"ng ien"l eng"n  Acute Inflammatory

     Idiopathic Polyneuropathy (AII) ""* -"ng #i" *g" ie#* e#"g"i Acute Inflammatory

     Demyelinating Polyneuropathy (AID) ""l" *"*  pen-"i p"" **n"n "r"? -"ng

    er"i e"r" "* "n ,en-el*r*+ er*","  ,engen"i r"i "n "r"? epi+ ""ng8

    ""ng ,engen"i "r"? o" -"ng i"*l*i ole in?ei.18&

    M"ni?e"i lini *"," "ri SGB ""l" *"* el*,p*"n -"ng i,eri ipe

    lower motor neuron "ri oo8oo ere,i"+ #""n "n ""ng8""ng *g" ,*".

    en-"i ini ,er*p""n pen-"i i,"n" ie, i,*ni" *#* ,en-er"ng el "r"?.

    4el*,p*"n i,*l"i p"" #"gi"n i"l ere,i" #"3" "n "p" n"i e "r" r"ni"l

    ( Ascending Paralysis) eng"n "r"erii ""n-" ele,""n "re?lei" -"ng #eri?"

     progrei? "n per*#""n en"i enori. Ge"l" enori ,*n*l eel" ""n-"

    ele,""n ,oori.'87

    SGB ering e"li #er*#*ng"n eng"n in?ei "* non pei?i. Inieni "*

    SGB -"ng #er"i"n eng"n in?ei ini ei"r "n"r" 56 8 %0+ -"i* 1 ",p"i ' ,ingg*

    e#el*, ge"l" ne*rologi i,#*l eperi in?ei "l*r"n pern"?""n "" ""* in?ei

    g"roinein"l. 2+%

    4el"in"n ini *g" "p" ,en-e#"#"n e,"i"n+ p"" & p"ien+ -"ng ie#"#"n

    ole g"g"l n"p" "n "ri,i". Ge"l" -"ng er"in-" #i""n-" il"ng & ,ingg* eel"

    ge"l" per"," "li i,#*l. Sei"r &0 peneri" ,e,ilii ge"l" i" ele,""n eel" &

    "*n. Tig" peren p"ien eng"n SGB "p" ,eng"l",i rel"p -"ng le#i ring"n #e#er"p"

    "*n eel" one per",". Bil" er"i e",#*"n ""* i" "" per#"i"n p"" "ir 

    ,ingg* I> ,"" er,"* Chronic Inflammantory Demyelinating Polyradiculoneuropathy

    (ID). S",p"i "" ini #el*, "" er"pi pei?i *n* SGB. engo#""n e"r"i,o,"i "n per"3""n -"ng #"i "p" ,e,per#"ii prognoin-".2+7

    DFINISI

     Parry ,eng"""n #"3"+ Sinro," G*ill"in B"rre (SGB) ""l" *"*

     poline*rop"i -"ng #eri?" ascending "n "* -"ng ering er"i eel" 1 ",p"i &

    ,ingg* eel" in?ei "*. Men*r*  Bosch+ SGB ,er*p""n *"* inro," lini

    -"ng i"n"i ""n-" p"r"lii ?l"i -"ng er"i e"r" "* #er*#*ng"n eng"n

     proe "*oi,*n i,"n" "rgen-" ""l" "r"? peri?er+ r"i+ "n ner!* r"ni"li.7

    Be#er"p" n"," ie#* ole #e#er"p" "li *n* pen-"i ini+ -"i* Idiopathic

     polyneuritis Acute !ebrile Polyneuritis Infective Polyneuritis Post    Infectious

     Polyneuritis Acute Inflammatory Demyelinating    Polyradiculoneuropathy "uillain Barre Strohl Syndrome #andry Ascending    paralysis dan #andry "uillain Barre

    Syndrome.7

    KLASIFIKASI

    Beri* er"p" l"i?i"i "ri SGB+ -"i*9&+5+$

    $% Acute &otor'Sensory A(onal )europathy (AMSAN) Sering ,*n*l ep" "n

    ,eng"l",i p"r"lii -"ng #er" eng"n per#"i"n -"ng l",#" "n #*r*. Seperi

    ipe AMAN -"ng #er*#*ng"n eng"n in?ei "l*r"n ern" C jejuni. "ologi -"ng

    ie,*"n ""l" egener"i "on "ri er"#* "r"? enori "n ,oori -"ng

     #er" eng"n eii e,ielini"i.

    10

  • 8/19/2019 Case CIDP Elva Gabriella

    11/17

    *% Acute &otor'A(onal )europa- (AMAN) Ber*#*ng"n eng"n in?ei "l*r"n

    ern" C jejuni "n ier "ni#o- g"nglioi ,ening" (eperi+ GM1+ GD1"+

    GD1#). eneri" ipe ini ,e,ilii ge"l" lini ,oori "n e"r" lini "

    *n* ipe e,ielini"i eng"n "ening "n p"r"l-i i,eri. AMAN i#e""n

    eng"n "il *i eleroi"gnoi i,"n" i"p""n ""n-" "onop"i ,oori."" #iop- ,en*n*"n egener"i +wallerian li,e- "np" in?l","i li,?oii.

    er#"i"nn-" ep"+ i"#ili" -"ng i"l",i peneri" el"," le#i *r"ng 1 "*n.

    .% &iller !isher Syndrome >"ri"i "ri SGB -"ng *,*, "n ,er*p""n 5 "ri

    e,*" "* SGB. Sinro," ini eriri "ri ""i"+ op"l,oplegi" "n "re?lei".

    A"i" erli" p"" g"-" "l"n "n p"" #""ng *#* "n "r"ng -"ng ,elip*i

    ere,i". Moori #i""n-" i" eren". er#"i"n e,p*rn" er"i "l",

    i*ng"n ,ingg* ""* #*l"n.

    /% Chronic Inflammatory Demyelinative Polyneuropathy (ID) ID ,e,ilii

    g",#"r"n lini eperi AID+ e"pi pere,#"ng"n ge"l" ne*rologin-" #eri?"roni. "" e#"gi"n "n"+ el"in"n ,oori le#i o,in"n "n ele,""n oo

    le#i #er" p"" #"gi"n i"l.

    0% Acute pandysautonomia  T"np" enori "n ,oori ,er*p""n ipe SGB -"ng

     "r"ng er"i. Di?*ngi "ri ie, i,p"i "n p"r"i,p"i -"ng #er"

    ,eng"i#""n er"in-" ipoeni po*r"l+ reeni "l*r"n e,i "n "l*r"n

    ern"+ "niroi+ pen*r*n"n "l!i" "n l"ri,"i "n "#nor,"li" "ri p*pil.

    "I+L+,I

    en-e#"# SGB i" ie"*i+ e"pi ering i*#*ng"n eng"n pen-"i

    in?ei+ eperi in?ei "l*r"n n"?" "n "l*r"n ern". >ir* -"ng p"ling ering

    ,en-e#"#"n pen-"i ini ""l" Cytomegalovirus (M>)+ :I>+ &easles "n :erpe

    Si,ple; >ir*. Se"ng"n *n* pen-e#"# #"eri p"ling ering ole Campylobacter 

     jejuni.7+10

    PA"+,NSIS

    Me"ni,e #"g"i,"n" in?ei+ !"in"i+ r"*,"+ ""* ?"or l"in -"ng

    ,e,preipi"i er"in-" e,ielini"i "* p"" SGB ,"i #el*, ie"*i eng"n

     p"i. B"n-" "li ,e,#*" ei,p*l"n #"3" er*""n "r"? -"ng er"i p""

    inro," ini ""l" ,el"l*i ,e"ni,e i,*nlogi. B*i8#*i #"3" i,*nop"ogene"

    ,er*p""n ,e"ni,e -"ng ,eni,#*l"n e" "r"? epi p"" inro," ini ""l"9

    7

    $% Di"p""nn-" "ni#oi ""* ""n-" repon ee#"l"n el*ler (cell mediated 

    immunity) er""p "gen in?ei* p"" "r"? epi. 

    *% A"n-" "*o "ni#oi er""p ie, "r"? epi.

    .% Di"p""nn-" peni,#*n"n o,ple "nigen "ni#oi "ri pere"r"n p""

     pe,#*l* "r" "r"? epi -"ng ,eni,#*l"n proe e,ielini"i "r"? epi.

    roe e,ielini"i "r"? epi p"" SGB ipeng"r*i ole repon i,*ni"

    el*ler "n i,*ni" *,or"l -"ng ipi* ole #er#"g"i perii3" e#el*,n-".'+7

    "" SGB+ g"nglioi ,er*p""n "rge "ri "ni#oi. I""n "ni#o- "l",

    ie, i,*n *#* ,eng"i!"i er"in-" er*""n p"" ,-elin. Al""n ,eng"p"

    o,ponen nor,"l "ri er"#* ,ielin ini ,en"i "rge "ri -e, i,*n #el*,

    ie"*i+ e"pi in?ei ole !ir* "n #"eri i*g" e#"g"i pen-e#"# ""n-" repon

    11

  • 8/19/2019 Case CIDP Elva Gabriella

    12/17

    "ri "ni#oi ie, i,*n *#*. :"l ini i"p""n "ri ""n-" l"pi"n lipopoli""ri"

    -"ng ,irip eng"n g"nglioi "ri *#* ,"n*i". Campylobacter jejuni+ #"eri

     p"ogen -"ng ,en-e#"#"n er"in-" i"re+ ,eng"n*ng proein ,e,#r"n -"ng

    ,er*p""n ir*"n "ri g"nglioi GM1. "" "* in?ei ole Campylobacter jejuni+

    er*""n er*"," er"i p"" egener"i "on. er*#""n p"" "on ini,en-e#"#"n ""n-" cross'reacting   "ni#oi e #en* g"nglioi GM1 *n* 

    ,erepon ""n-" epiop -"ng ",". '+7+10

    Ber""r"n ""n-" in-"l in?ei -"ng ,enginii"i i,*ni" *,or"l ,""

    el8T ,erepon eng"n ""n-" in?ilr"i li,?oi e pin"l "n "r"? peri?er. Ter#en* 

    ,"ro?"g i "er" er*""n "n ,en-e#"#"n ""n-" proe e,ielini"i "n

    ",#""n peng"n"r"n i,p*l "r"?.'+7

    PA"+L+,I

    "" pe,eri""n ,"roopi i" ",p" el" g",#"r"n pe,#eng""n

    "r"? epi. Deng"n ,iroop in"r ",p" per*#""n p"" "r"? epi. er*#""n

     per"," #er*p" ee," -"ng er"i p"" "ri e8ig" ""* ee,p"+ e,*i"n i,#*l pe,#eng""n "n ireg*l"ri" el*#*ng ,ielin p"""ri e8li,"+ erli" #e#er"p"

    li,?oi p"" "ri e8e,#il"n "n ,"ro?"g p"" "ri e8e#el"+ poli?er"i el 3"n

     p"" "ri e8ig" #el". er*#""n p"" ,ielin+ "on+ "n el*#*ng 3"n #er"l"n

    e"r" progrei?+ eingg" p"" "ri e8en", p*l* en",+ e#"gi"n r"i "n "r"? epi

    el" "n*r.'+7

    A#*r- ,enge,*""n #"3" per*#""n per"," -"ng er"i ""l"

    in?ilr"i el li,?oi -"ng er"!""i "ri pe,#*l* "r" eil p"" eno "n

    epine*r"l. 4e"""n ini eger" ii*i e,ielini"i eg,en"l. Bil" per""ng"nn-" #er"

    ""n #ere,#"ng ,en"i egener"i 1allerian. 4er*""n ,-elin ie#"#"n

    ,"ro?"g -"ng ,ene,#* ,e,#r"n #""li "n ,elep""n el*#*ng ,ielin "ri el

    3"n "n "on.'+7

    DIA,N+SIS

    Di"gnoi SGB er*"," ieg""n e"r" lini. SBG i"n"i eng"n

    i,#*ln-" *"* el*,p*"n "* -"ng ier"i il"ngn-" re?le8re?le enon "n

    i"*l*i p"reei *" ""* ig" ,ingg* eel" ,eng"l",i e,", ier"i ioi"i

    io"l#*,in p"" li*or "n g"ngg*"n enori "n ,oori peri?er.5

    ,e>ala Klinik 

    SGB ,er*p""n pen-e#"# p"r"lii "* -"ng i,*l"i eng"n r"" #""l+

     p"reei" p"" #"gi"n i"l "n ii*i e"r" ep" ole p"r"lii e8e,p" ere,i"-"ng #eri?" "enen. "reei" ini #i""n-" #eri?" #il"er"l. Re?le ?iiologi ""n

    ,en*r*n "n e,*i"n ,engil"ng "," e"li.6+7

    4er*""n "r"? ,oori #i""n-" i,*l"i "ri ere,i" #"3" "n ,en-e#"r 

    e"r" progrei? e ere,i" ""+ *#* "n "r"? p*". 4er*""n "r"? ,oori ini

     #er!"ri"i ,*l"i "ri ele,""n ",p"i p"" -"ng ,eni,#*l"n 2uadriplegia flacid .

    4eerli#""n "r"? p*"+ ,*n*l p"" 50 "*+ #i""n-" #er*p"  facial diplegia.

    4ele,""n oo pern"p""n "p" i,#*l e"r" igni?i"n "n #""n 20 p"ien

    ,e,erl*"n #"n*"n !enil"or "l", #ern"?". 7+10+11

    4er*""n "r"? enori -"ng er"i *r"ng igni?i"n i#"ning"n eng"n

    ele,""n p"" oo. R"" "i "n r", *g" "p" ,en-er"i ele,""n oo -"ng

    er"i er*"," p"" "n"8"n".&+ 12

    12

  • 8/19/2019 Case CIDP Elva Gabriella

    13/17

    4el"in"n "r"? oono, i" "r"ng er"i "n "p" ,eni,#*l"n e,"i"n.

    4el"in"n ini "p" ,eni,#*l"n "i"ri+ ipoeni ""* ipereni+ "ri,i" #""n

    cardiac arrest +  facial flushing + ?inger -"ng i" eronrol+ "n el"in"n "l",

     #erering". 4er*""n p"" **n"n "r"? p*" "p" ,eni,#*l"n ge"l" #er*p"

    i?"gi"+ e*li"n "l", #er#i"r"+ "n -"ng p"ling ering (50) ""l" bilateral  facial palsy%&+7+10+11

    Ge"l"8ge"l" ",#""n -"ng #i""n-" ,en-er"i SGB ""l" e*li"n *n* 

    ,*l"i BA4+ inonineni" *rin "n "l!i+ onip"i+ e*li"n ,enel"n "n #ern"p"+

     per"""n i" "p" ,en"ri n"p" "l",+ "n pengli""n "#*r 3blurred visions4%&+12+1&

    Pe#eriksaan Fisik

    "" pe,eri""n ne*rologi ie,*"n ""n-" ele,""n oo -"ng  #eri?"

    i?* "n p"r"lii. Re?le enon ""n ,en*r*n ""* #""n ,engil"ng. B"* -"ng

    le," "n "pir"i ,engini"i"n ""n-" ele,""n  p"" oo8oo inero"l. T"n"

    r"ng"ng ,eninge"l eperi per"" ernig "n "* ** ,*ngin ie,*"n. Re?le

     p"ologi eperi re?le B"#in- i" ie,*"n.&

    Pe#eriksaan Penun>an&

    1. e,eri""n S D"ri pe,eri""n S i"p""n ""n-" en"i"n ""r 

     proein ( 1 1+5 g/l ) "np" ii*i en"i"n *,l" el. 4e"""n ini ole

    G*ill"in (1$61) ie#* e#"g"i ioi"i "l#*,in iologi. e,eri""n "ir"n

    ere#ropin"l p"" '% ", per"," pen-"i i" ,e,#eri"n "il "p"p*n

     *g". 4en"i"n ""r proein #i""n-" er"i p"" ,ingg* per"," ""* e*".

    4e#"n-""n pe,eri""n S p"" p"ien ""n ,en*n*"n *,l" el -"ng

    *r"ng "ri 10/,,& (albuminocytologic dissociation).1+%

    2. e,eri""n MG G",#"r"n MG p"" "3"l pen-"i ,"i "l", #""

    nor,"l+ el*,p*"n er"i p"" ,ingg* per"," "n p*n"n-" p"" "ir 

    ,ingg* e*" "n p"" "ir ,ingg* e ig" ,*l"i ,en*n*"n ""n-"

     per#"i"n. "" pe,eri""n MG ,ingg* per"," "p" ili" ""n-"

    eerl",#""n ""* #""n #lo "l", peng"n"r"n i,p*l+ gelo,#"ng F -"ng

    ,e,"n"ng "n l"eni i"l -"ng ,e,"n"ng. Bil" pe,eri""n il"*"n

     p"" ,ingg* e 2+ ""n erli" ""n-" pen*r*n"n poeni"l "i (MA) "ri

     #e#er"p" oo+ "n ,en*r*nn-" eep""n on*i "r"? ,oori.%

    &. e,eri""n MRI e,eri""n MRI ""n ,e,#eri"n "il -"ng #er,"n" i"

    il"*"n ir"8ir" p"" "ri e81& eel" i,#*ln-" ge"l". MRI ""n

    ,e,perli""n g",#"r"n "*" e*in" -"ng #er",#" #e"r. :"l ini "p"

    erli" p"" $5 "* SGB.

    7

    ". e,eri""n er*, 4 #i""n-" nor,"l ""* ,ening" eii.1

     #. Biopi oo i" iperl*"n "n #i""n-" nor,"l p"" "i*, "3"l. ""

    "i*, l"n* erli" ""n-" denervation atrophy.1

    KRI"RIA DIA,N+S"IK 

    4rieri" i"gnoi SGB ,en*r* 5he )ational Institute of )eurological and 

    Communicative Disorders and Stro,e ( NINDS).6

    1&

  • 8/19/2019 Case CIDP Elva Gabriella

    14/17

    ,e>ala uta#a :

    1. 4ele,""n -"ng #eri?" progrei? p"" "* ""* le#i ere,i" eng"n ""*

    "np" ier"i "";i"

    2. Are?lei" ""* ipore?lei" -"ng #eri?" gener"l

    ,e>ala ta#%a(an :

    1. rogrei?i"9 ge"l" ele,""n ,oori #erl"ng*ng ep"+ ,"i,"l "l", '

    ,ingg*+ 50 ,en"p"i p*n" "l", 2 ,ingg*+ %0 "l", & ,ingg*+ "n

    $0 "l", ' ,ingg*.

    2. Rel"i? i,eri.

    &. Ge"l" g"ngg*"n eni#ili" ring"n.

    '. Ge"l" "r"? r"ni"l+ 50 er"i p"ree N >II "n ering #il"er"l. S"r"? o" 

    l"in "p" eren" **n-" -"ng ,e,per"r"?i li" "n oo8oo ,enel"n+

    ""ng H 5 "* ne*rop"i i,*l"i "ri oo er"o*ler ""* "r"? o" l"in.

    5. e,*li"n9 i,*l"i 28' ,ingg* eel" progrei?i" #ereni+ "p" ,e,"n"ng",p"i #e#er"p" #*l"n.

    6. Di?*ngi oono,. T"i"ri "n "ri,i"+ ipoeni po*r"l+ ipereni "n

    ge"l" !"o,oor.

    7. Ti" "" e,", "" one ge"l" ne*rologi

    Pe#eriksaan LCS :

    1. ening""n proein

    2. Sel MN H 10 /*l

    Pe#eriksaan elektrodia&nostik 9 erli" ""n-" perl",#""n ""* #lo p""

    on*i i,p*l "r"? 

    PNA"ALAKSANAAN

    S",p"i "" ini #el*, "" pengo#""n pei?i *n* SGB+ pengo#""n er*","

    e"r" i,po,"i. T**"n *"," pen""l""n""n ""l" ,eng*r"ngi ge"l"+

    ,engo#"i o,pli"i+ ,e,perep" pen-e,#*"n "n ,e,per#"ii prognoin-".

    eneri" p"" "i*, "3"l perl* ir"3" i r*," "i *n* er* il"*"n

    o#er!"i "n"8"n" !i"l. eneri" eng"n ge"l" #er" "r* eger" i r"3" i

    r*," "i *n* ,e,"p""n #"n*"n pern"?""n+ pengo#""n "n ?iioer"pi. 7+12+1&

    A"p*n pen""l""n""n -"ng "p" il"*"n ""l" 9 

    7' Fisiotera0i

    Fiioer"pi "" e"r" er"*r *n* ,eneg" reeni p**, "n ol"p p"r*.

    Ger""n p"i? p"" "i -"ng l*,p* ,eneg" e"*"n eni. Seger" eel"

     pen-e,#*"n ,*l"i (?"e reon!"leen)+ ,"" ?iioer"pi "i? i,*l"i *n* ,el"i

    "n ,ening""n e*""n oo.7

    5' Plasma exchange therapy -P/

    l","p"rei ""*  plasma e(change  #er**"n *n* ,engel*"r"n ?"or 

    "*o"ni#oi -"ng #ere"r. e,""i"n pl","p"rei p"" SGB ,e,perli""n "il

    -"ng #"i+ #er*p" per#"i"n lini -"ng le#i ep"+ pengg*n""n "l" #"n* n"?" -"ng

    le#i eii+ "n l"," per"3""n -"ng le#i pene. "* -"ng p"ling e?ei? *n* 

    1'

  • 8/19/2019 Case CIDP Elva Gabriella

    15/17

    ,el"*"n ""l" "l", 2 ,ingg* eel" ,*n*ln-" ge"l". J*,l" pl"," -"ng

    iel*"r"n per e(change ""l" '0850 ,l/g "l", 3"* 7810 "ri il"*"n e,p"

    ",p"i li," "li e(change. 7

    ' I#uno&lo%ulin I1 Intravenous inffusion of human Immunoglobulin (I>Ig) "p" ,ener"li"i

    "*o"ni#oi p"ologi -"ng "" ""* ,ene"n pro*i "*o "ni#oi ere#*. I>Ig

     *g" "p" ,e,perep" ""#oli,e IgG+ -"ng e,*i"n ,ener"liir "nigen "ri

    !ir* ""* #"eri eingg" T ell p"ologi i" er#en*.7

    engo#""n eng"n g",," glo#*lin inr"!en" le#i ,eng*n*ng"n

    i#"ning"n pl","p"rei "ren" e?e ",ping/o,pli"i le#i ring"n. e,#eri"n

    I>Ig ini il"*"n "l", 2 ,ingg* eel" ge"l" ,*n*l eng"n oi 0+' g / gBB

    /"ri el"," 5 "ri. e,#eri"n io,#in"i"n eng"n I>Ig i" ,e,#eri"n "il

    -"ng le#i #"i i#"ning"n eng"n "n-" ,e,#eri"n ""* I>Ig.2+'

    4. Kortikosteroid4e#"n-""n penelii"n ,eng"""n #"3" pengg*n""n prep"r" eroi i" 

    ,e,p*n-"i nil"i/i" #er,"n?"" *n* er"pi SGB. Te"pi+ ig*n""n p"" SGB ipe

    ID.%+11

    K+MPLIKASI

    4o,pli"i -"ng "p" er"i ""l" g"g"l n"p"+ "pir"i ,""n"n ""* "ir"n

    e "l", p"r*+ pne*,oni"+ ,ening""n reio er"in-" in?ei+ ro,#oi !en"

    "l",+ p"r"lii per,"nen p"" #"gi"n *#* eren*+ "n onr"*r p"" eni.7+12

    PR+,N+SIS

    "" *,*,n-" peneri" ,e,p*n-"i prognoi -"ng #"i+ e"pi p"" e#"gi"n

    eil peneri" "p" ,eningg"l ""* ,e,p*n-"i ge"l" i". eneri" SGB "p"

    e,#* e,p*rn" (758$0) ""* e,#* eng"n ge"l" i" #er*p" dropfoot ""*

    re,or po*r"l (258&6).7

    en-e,#*"n "p" ,e,""n 3"* #e#er"p" ,ingg* ","p"i #e#er"p" "*n.

    Men*r* )ational Institute of )eurological Disorders and Stro,e ei"r &0 peneri"

    ,"i ,eng"l",i ge"l" i" eel" & "*n (ge"l" i" ring"n "p" ,ene"p p""

     peneri"). 4el*"r"n peneri" ""n ,en"i "ng" #"i #il" ge"l"8ge"l" "p" il"ng

    "l", 3"* & ,ingg* e" ,*n*l ge"l" ere#* ,*n*l.6

    4el"in"n ini *g" "p" ,en-e#"#"n e,"i"n+ p"" & p"ien+ -"ng

    ie#"#"n ole g"g"l n"p" "n "ri,i". Ge"l" -"ng er"in-" #i""n-" il"ng &,ingg* eel" ge"l" per"," "li i,#*l. Sei"r &0 peneri" ,e,ilii ge"l" i

    ele,""n eel" & "*n. Tig" peren p"ien eng"n SGB "p" ,eng"l",i rel"p

    -"ng le#i ring"n #e#er"p" "*n eel" one per",". 6+7+%

    Bil" er"i e",#*"n ""* i" "" per#"i"n p"" "ir ,ingg* I> ,""

    er,"* Chronic Inflammantory Demyelinating Polyradiculoneuropathy (ID).1+$

    DAF"AR PUS"AKA

    15

  • 8/19/2019 Case CIDP Elva Gabriella

    16/17

    1. Soll BJ+ 4lieg,"n RM. Behrman')elson Pediatric 5e(tboo, . enn-l!"ni"

    9S"*ner in+ 200'.

    2. A", RD+ >ior M+ Ropper A:. Principles of )eurology 6th 7d . SA 9 MGr"3:ill+ 2005.

    &. D"!i :R. "uillain'Barre Syndrome' Available from 9 R 9

    p9//e,eiine.,e"pe.o,/"rile/&156&28o!er!ie3. i"e "ngg"l 2& J*ni

    2011K. #ast 8pdate L 2011.

    '. Mene J:+ S"rn" :B+ Moer FG. Child )eurology 9 th 7d . onon 9 illi",

    ilin+ 2000.

    5. S"? eng""r F4 I. Il,* 4ee""n An". J""r" 9 F4 I+ 1$%5.

    6. N"ion"l Ini*e o? Ne*rologi"l Diorer "n Sroe. "uillan'Barre Syndrome.

    200$. Available from 9 R 9

    p9//333.nin.ni.go!/iorer/g#/g#.,*#li"ion. i"e "ngg"l 22

    J*ni 2011K. #ast update L 2011.7. J"p"ri I. Sinro," G*ill"n8B"rre. F4 S B"gi"n Be". Available from 9 R 9

    p9//li#r"r-.**.".i/o3nlo"/?/#e"8i"n"r20"p"ri'6.p? . i"e

    "ngg"l 22 J*ni 2011K. #ast update L 2002.

    %. ilinon I+ enno; G. 7ssential )eurology /th 7d . 4 9 Bl"3ell *#liing+

    2005.

    $. R",""nr"n TS. Acute Inflammatory Demyelinating Polyradiculoneuropathy% 

     Available from 9 R 9 p9//e,eiine.,e"pe.o,/"rile/116$$5$8o!er!ie3. 

    i"e "ngg"l 22 J*ni 2011K. #ast update L 200$.

    10. Miller A. "uillain'Barre Syndrome' Available from 9 R 9

    p9//e,eiine.,e"pe.o,/"rile/7$200%8o!er!ie3. i"e "ngg"l &

    Sepe,#er 200$K. #ast update L 200$.11. e3i RA. Chronic Inflammatory Demyelinating Polyradiculoneuropathy' 

     Available from 9 R 9 p9//e,eiine.,e"pe.o,/"rile/1172$658o!er!ie3.

    i"e "ngg"l 2& J*ni 2011K. #ast update L 2010.

    12. M"-o lini S"??. "uillain Barre Syndrome. Available from 9 R 9

    p9//333.,"-olini.o,/e"l/g*ill"in#"rre-nro,e/DS00'1&/ i"e

    "ngg"l 2& J*ni 2011K.

    1&. ,eiine S"??. "uillan'Barre Syndrome. Available from 9 R 9

    p9//333.e,eiinee"l.o,/g*ill"in8#"rreO-nro,e/"rileOe,.,. i"e

    "ngg"l 2' J*ni 2011K.

     Laporan Kasus

    16

    http://library.usu.ac.id/download/fk/bedah-iskandar%20japardi46.pdfhttp://emedicine.medscape.com/article/1169959-overviewhttp://emedicine.medscape.com/article/1172965-overviewhttp://www.emedicinehealth.com/guillain-barre_syndrome/article_em.htmhttp://emedicine.medscape.com/article/1169959-overviewhttp://emedicine.medscape.com/article/1172965-overviewhttp://www.emedicinehealth.com/guillain-barre_syndrome/article_em.htmhttp://library.usu.ac.id/download/fk/bedah-iskandar%20japardi46.pdf

  • 8/19/2019 Case CIDP Elva Gabriella

    17/17

    SINDR+M ,UILLAIN !ARR

    Disusun ole( :

    Mu(a##ad Sukri Dini(ar

    6?6@777?4

    Pe#%i#%in& : dr' Riki Sukiandra9 S0'S

    Ke0aniteraan Klinik Senior -KKS/ – !a&ian Il#u Saraf 

    Fakultas Kedokteran Uniersitas Riau

    RSUD Arifin A.(#ad

    Pekan%aru

    5677

    17